348782097	348782097	CD	B-NP	O
|	|	NN	I-NP	O
TNH	TNH	NN	I-NP	O
|	|	NN	I-NP	O
18933515	18933515	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3289356	3289356	CD	B-NP	O
|	|	CC	I-NP	O
8/21/2004	8/21/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
SEVERE	SEVERE	NNP	I-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	I-NP	O
,	,	,	O	O
CHEST	CHEST	NNP	B-NP	O
PAIN	PAIN	NNP	I-NP	O
,	,	,	O	O
POSTIVE	POSTIVE	NNP	B-NP	O
THALLIUM	THALLIUM	NNP	I-NP	O
STRESS	STRESS	NNP	I-NP	O
TEST	TEST	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2004	11/13/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2004	10/28/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MORRIS	MORRIS	NNP	B-NP	O
VALLOT	VALLOT	NNP	I-NP	O
MD	MD	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Anemia	Anemia	NN	B-NP	O
,	,	,	O	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
past	past	JJ	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
medical	medical	JJ	I-NP	O
issues	issue	NNS	I-NP	O
including	include	VBG	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
nonobstructive	nonobstructive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
of	of	IN	B-PP	O
1993	1993	CD	B-NP	O
and	and	CC	O	O
idiopathic	idiopathic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
reported	report	VBN	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Burgthan	Burgthan	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
prior	prior	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
Montsair	Montsair	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
from	from	IN	B-PP	O
1994	1994	CD	B-NP	O
reported	report	VBD	B-VP	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
alcoholic	alcoholic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	JJ	B-ADJP	O
post	post	IN	B-PP	O
right	right	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
CVA	CVA	NNP	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
x	x	SYM	B-NP	O
several	several	JJ	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
noted	note	VBD	B-VP	O
initial	initial	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
nonproductive	nonproductive	JJ	B-NP	O
cough	cough	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
9/24	9/24	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
film	film	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
content	content	NN	I-NP	O
question	question	NN	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
late	late	JJ	B-NP	O
9/24	9/24	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
progressive	progressive	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
particularly	particularly	RB	B-ADVP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
of	of	IN	B-PP	O
steps	step	NNS	B-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
a	a	DT	B-NP	O
vague	vague	JJ	I-NP	O
band	band	NN	I-NP	O
like	like	IN	B-PP	O
pain	pain	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
chest	chest	NN	I-NP	O
particularly	particularly	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
of	of	IN	B-PP	O
steps	step	NNS	B-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
supine	supine	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
or	or	CC	O	O
recent	recent	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
are	be	VBP	B-VP	O
notably	notably	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
resolution	resolution	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-NP	O
recall	recall	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
palpitation	palpitation	NN	B-NP	O
or	or	CC	O	O
raising	raise	VBG	B-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
intermittent	intermittent	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
hematochezia	hematochezia	NN	B-NP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
hematemesis	hematemesis	NN	B-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
melanotic	melanotic	JJ	B-NP	O
stools	stool	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
Lan	Lan	NNP	B-NP	O
,	,	,	O	O
West	West	NNP	B-NP	O
Virginia	Virginia	NNP	I-NP	O
39586	39586	CD	I-NP	O
several	several	JJ	I-NP	O
years	year	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

EGD	EGD	NN	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
both	both	CC	O	O
upper	upper	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
GI	GI	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
including	include	VBG	B-PP	O
several	several	JJ	B-NP	O
small	small	JJ	I-NP	O
AVM	AVM	NN	I-NP	O
and	and	CC	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
GI	GI	NN	I-NP	O
endoscopy	endoscopy	NN	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
duodenitis	duodenitis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Pleaermount	Pleaermount	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
today	today	NN	B-NP	O
reportedly	reportedly	RB	B-ADVP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
rhtyhm	rhtyhm	NN	I-NP	O
that	that	WDT	B-NP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
120s	120s	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
appeared	appear	VBN	I-VP	O
pale	pale	JJ	B-ADJP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
obtained	obtain	VBN	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
reportedly	reportedly	RB	B-ADVP	O
21.4	21.4	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Nipaul	Nipaul	NNP	I-NP	O
Ingways	Ingways	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
is	be	VBZ	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
recent	recent	JJ	B-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
reports	report	VBZ	B-VP	O
intermittent	intermittent	JJ	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
six	six	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
given	give	VBN	B-VP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
nonobstructive	nonobstructive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
IDCM	IDCM	NN	B-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
to	to	TO	I-NP	O
45	45	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
alcoholic	alcoholic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
CVA	CVA	NNP	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
with	with	IN	B-PP	O
duodenitis	duodenitis	NN	B-NP	O
,	,	,	O	O
diverticulitis	diverticulitis	NN	B-NP	O
and	and	CC	O	O
AVM	AVM	NN	B-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
partial	partial	JJ	I-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
and	and	CC	I-NP	O
depression	depression	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Niacin	Niacin	NN	B-NP	B-protein
750	750	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Folate	Folate	JJ	B-NP	O
B6	B6	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Avandia	Avandia	NNP	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Valsartan	Valsartan	NNP	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Nifedipine	Nifedipine	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Bisoprolol	Bisoprolol	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Glucophage	Glucophage	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
14	14	CD	I-NP	I-protein
.	.	.	O	O

Gemfibrozil	Gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Reported	Report	VBN	B-NP	O
isosorbide	isosorbide	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
erectile	erectile	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	I-NP	O
Viagra	Viagra	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
reportedly	reportedly	RB	B-ADVP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
work	work	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
50-pack-year	50-pack-year	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
smoke	smoke	VB	I-VP	O
several	several	JJ	B-NP	O
cigarettes	cigarette	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Past	Past	NN	B-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
though	though	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
girlfriend	girlfriend	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
local	local	JJ	B-ADJP	O
to	to	TO	B-PP	O
O	O	NNP	B-NP	O
Lasmerflinteans	Lasmerflinteans	NNP	I-NP	O
Louis	Louis	NNP	I-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Family	Family	RB	B-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
noncontributory	noncontributory	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
death	death	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
112	112	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
168/90	168/90	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
93	93	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
though	though	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
12	12	CD	I-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
,	,	,	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
given	give	VBN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
additionally	additionally	RB	B-ADVP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
one-third	one-third	NN	B-NP	O
to	to	TO	B-VP	O
one-half	one-half	NN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
egophony	egophony	NN	I-NP	O
or	or	CC	I-NP	O
consolidation	consolidation	NN	I-NP	O
was	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
4/5	4/5	CD	B-NP	O
strength	strength	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-SBAR	O
right	right	NN	B-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
calf	calf	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
values	value	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
are	be	VBP	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
and	and	CC	I-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
192	192	CD	B-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limit	limit	NN	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
8.7	8.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
21.4	21.4	CD	B-NP	O
,	,	,	O	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
to	to	TO	I-NP	O
35	35	CD	I-NP	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
351	351	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

MCV	MCV	NN	B-NP	O
on	on	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	B-DNA
was	be	VBD	B-VP	I-DNA
84	84	CD	B-NP	I-DNA
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
irregularly	irregularly	RB	B-NP	O
regular	regular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
120	120	CD	B-NP	O
likely	likely	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
versus	versus	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
variable	variable	JJ	B-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
ST	ST	NN	B-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O
laterally	laterally	RB	B-ADVP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
question	question	NN	B-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
versus	versus	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
bundle	bundle	NN	B-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
reportedly	reportedly	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
film	film	NN	I-NP	O
with	with	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
prominence	prominence	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hilum	hilum	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
question	question	NN	B-NP	O
mass	mass	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
over	over	IN	B-ADVP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
overt	overt	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
past	past	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
and	and	CC	I-NP	O
otherwise	otherwise	RB	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
presenting	present	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Mahunt	Mahunt	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NNP	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	VBN	B-VP	O
with	with	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
20s	20s	CD	I-NP	O
and	and	CC	O	O
question	question	NN	B-NP	O
community-acquired	community-acquired	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
at	at	IN	B-PP	O
120	120	CD	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
complaint	complaint	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	set	VBG	I-NP	O
significant	significant	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
known	know	VBN	B-VP	O
ventricular	ventricular	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
serially	serially	RB	B-VP	O
were	be	VBD	I-VP	O
elevated	elevate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
troponin	troponin	NN	I-NP	O
I	I	CD	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
serial	serial	JJ	I-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
resolved	resolve	VBN	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
IV	IV	CD	I-NP	O
drip	drip	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
following	follow	VBG	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Slaney	Slaney	NNP	I-NP	O
in	in	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
anticoagulation	anticoagulation	NN	B-NP	O
be	be	VB	B-VP	O
stopped	stop	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
versus	versus	IN	B-PP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
following	follow	VBG	I-NP	O
p.o.	p.o.	FW	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
,	,	,	I-NP	O
digoxin	digoxin	NN	I-NP	O
and	and	CC	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
lisinopril	lisinopril	VB	I-VP	O
40	40	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
given	give	VBN	I-VP	O
significant	significant	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	I-NP	O
8	8	CD	I-NP	O
liters	liter	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
obtained	obtain	VBN	B-VP	O
during	during	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
episode	episode	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
septal	septal	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
altered	alter	VBN	I-VP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
of	of	IN	B-PP	O
9/16/03	9/16/03	CD	B-NP	O
obtained	obtain	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Wellcamp	Wellcamp	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
revealed	reveal	VBN	I-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
40	40	CD	B-NP	O
to	to	TO	I-NP	O
45	45	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
global	global	JJ	I-NP	O
HK	HK	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
Alehealtdana	Alehealtdana	NNP	B-NP	O
Bafound	Bafound	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
system	system	NN	I-NP	O
from	from	IN	B-PP	O
1994	1994	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
issues	issue	NNS	I-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
stem	stem	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
anemia	anemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
and	and	CC	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	I-VP	O
demand	demand	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	I-NP	O
subsequent	subsequent	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
causing	cause	VBG	B-VP	O
decompensated	decompensate	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptomatology	symptomatology	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
proper	proper	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
70s	70	NNS	B-NP	I-DNA
and	and	CC	O	O
following	follow	VBG	B-VP	O
IV	IV	CD	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CHF	CHF	NN	I-NP	O
symptomatology	symptomatology	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
both	both	CC	I-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
GI	GI	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
including	include	VBG	B-PP	O
AVM	AVM	NN	B-NP	B-protein
and	and	CC	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
treated	treat	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	B-DNA
21.4	21.4	CD	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
stable	stable	JJ	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
29	29	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
x	x	CC	I-NP	O
72	72	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
unstable	unstable	JJ	I-ADJP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
precipitating	precipitating	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
further	further	RBR	B-NP	O
outpatient	outpatient	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
GI	GI	NN	I-NP	O
endoscopy	endoscopy	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rosendo	Rosendo	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Erpin	Erpin	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
and	and	CC	O	O
outpatient	outpatient	NN	B-NP	O
EGD	EGD	NN	I-NP	O
and	and	CC	O	O
colonoscopy	colonoscopy	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
or	or	CC	I-NP	O
two	two	CD	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
29	29	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
held	hold	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
giving	give	VBG	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	O	O
following	follow	VBG	B-VP	O
stable	stable	JJ	B-NP	O
transfusion	transfusion	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
initially	initially	RB	B-NP	O
5	5	CD	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
later	later	RB	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2.8	2.8	CD	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
be	be	VB	I-VP	O
further	further	RBR	B-ADJP	O
evaluated	evaluate	VBN	I-ADJP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
on	on	IN	B-PP	O
5/11/04	5/11/04	CD	B-NP	O
in	in	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Paider	Paider	NNP	I-NP	O
office	office	NN	I-NP	O
and	and	CC	I-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
precipitating	precipitate	VBG	I-VP	O
etiology	etiology	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
current	current	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
maintained	maintain	VBD	B-VP	O
on	on	IN	B-PP	O
IV	IV	NNP	B-NP	O
Protonix	Protonix	NNP	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
Prilosec	Prilosec	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
GI	GI	NN	B-NP	O
consult	consult	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
with	with	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
previously	previously	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
course	course	NN	B-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
presumably	presumably	RB	B-ADVP	O
Levaquin	Levaquin	NNP	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
community-acquired	community-acquired	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
giving	give	VBG	B-VP	O
ongoing	ongoing	JJ	B-NP	O
symptomatology	symptomatology	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
treated	treat	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
including	include	VBG	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
full	full	JJ	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
community-acquired	community-acquired	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
afebrile	afebrile	NN	I-NP	O
,	,	,	O	O
ambulating	ambulate	VBG	B-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
long	long	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
history	history	NN	I-NP	O
given	give	VBN	B-VP	O
extensive	extensive	JJ	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
addiction	addiction	NN	B-NP	O
consultation	consultation	NN	I-NP	O
regarding	regard	VBG	B-VP	O
tobacco	tobacco	NN	B-NP	O
cessation	cessation	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
consultation	consultation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
showing	show	VBG	B-VP	O
good	good	JJ	B-NP	O
promise	promise	NN	I-NP	O
regarding	regard	VBG	B-VP	O
tobacco	tobacco	NN	B-NP	O
cessation	cessation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
interest	interest	NN	B-NP	O
in	in	IN	B-PP	O
doing	do	VBG	B-VP	O
so	so	RB	B-ADVP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antianxiety	antianxiety	NN	I-NP	O
and	and	CC	I-NP	O
depression	depression	NN	I-NP	O
medications	medication	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
altered	alter	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
Zoloft	Zoloft	NNP	B-NP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
from	from	IN	B-PP	O
50	50	CD	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
that	that	IN	B-SBAR	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
discontinue	discontinue	VB	I-VP	O
his	his	PRP$	B-NP	O
Zoloft	Zoloft	NNP	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
Wellbutrin	Wellbutrin	NN	B-NP	O
initially	initially	RB	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
x	x	SYM	O	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
transition	transition	VB	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
b.i.d.	b.i.d.	VB	I-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
within	within	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
time	time	NN	I-NP	O
as	as	IN	B-SBAR	O
Zoloft	Zoloft	NNP	B-NP	O
is	be	VBZ	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
recommend	recommend	VB	B-VP	O
further	further	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
sundowning	sundowne	VBG	B-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
incidents	incident	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Avandia	Avandia	NNP	B-NP	O
and	and	CC	I-NP	O
Glucophage	Glucophage	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
additional	additional	JJ	B-NP	O
anti-glycemic	anti-glycemic	JJ	I-NP	O
medications	medication	NNS	I-NP	O
in	in	IN	B-PP	O
future	future	JJ	B-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronicrenal	chronicrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
presumed	presume	VBN	I-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
to	to	TO	B-PP	O
1.3	1.3	CD	B-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
cardiorenal	cardiorenal	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
decompensation	decompensation	NN	I-NP	O
,	,	,	O	O
recommend	recommend	VBP	B-VP	O
further	further	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
management	management	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mcculler	Mcculler	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Lumspe	Lumspe	NNP	I-NP	O
Black	Black	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
on	on	IN	B-PP	O
5/11/04	5/11/04	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
,	,	,	O	O
recommend	recommend	VBP	B-VP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
,	,	,	O	O
electrolyte	electrolyte	NN	B-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p	p	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Niacin	Niacin	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
750	750	CD	B-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Folate	Folate	JJ	B-NP	O
B6	B6	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Avandia	Avandia	NNP	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
valsartan	valsartan	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
nifedipine	nifedipine	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
bisoprolol	bisoprolol	NN	I-NP	O
,	,	,	O	O
instead	instead	RB	B-NP	O
substitute	substitute	JJ	I-NP	O
Toprol	Toprol	NNP	I-NP	O
XL	XL	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Glucophage	Glucophage	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
b.i.d.	b.i.d.	FW	I-NP	I-protein
15	15	CD	I-NP	I-protein
.	.	.	O	O

Gemfibrozil	Gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Zoloft	Zoloft	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
x	x	SYM	B-NP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Wellbutrin	Wellbutrin	NN	B-NP	O
SR	SR	NN	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

x	x	SYM	O	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
b.i.d.	b.i.d.	NN	B-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
22	22	CD	I-NP	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

Azithromycin	Azithromycin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
x	x	SYM	O	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

25	25	CD	B-NP	O
.	.	.	O	O

Cefpodoxime	Cefpodoxime	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
x	x	SYM	O	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
afebrile	afebrile	JJ	I-NP	O
and	and	CC	I-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ambulating	ambulate	VBG	B-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
and	and	CC	I-NP	O
feeling	feeling	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Alquesta	Alquesta	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Bridplacechael	Bridplacechael	NNP	I-NP	O
's	's	POS	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
further	further	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
as	as	IN	B-PP	O
potential	potential	JJ	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
further	further	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
work	work	NN	I-NP	O
up	up	RB	B-ADVP	O
including	include	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
time	time	NN	I-NP	O
given	give	VBN	B-VP	O
troponin	troponin	NN	B-NP	O
leak	leak	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-7064031	2-7064031	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
NELLER	NELLER	NNP	B-NP	O
,	,	,	O	O
TOM	TOM	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GIESSINGER	GIESSINGER	NN	B-NP	O
,	,	,	O	O
CORNELIUS	CORNELIUS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8722150	8722150	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/2/04	9/2/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/2/04	9/2/04	CD	B-NP	O

